Barclays’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Barclays’s Portfolio COV Stock Details COV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-1,130,200	Closed	-$115M	–	7578
2014 Q4	$115M	Sell	1,130,200 -140,600	-11%	-$13.5M	0.11%	145
2014 Q3	$109M	Buy	1,270,800 +1,182,400	+1,338%	+$105M	0.11%	147
2014 Q2	$7.96M	Sell	88,400 -89,700	-50%	-$6.71M	0.01%	1337
2014 Q1	$13M	Buy	178,100 +126,700	+246%	+$8.84M	0.01%	960
2013 Q4	$3.5M	Sell	51,400 -10,100	-16%	-$657K	﹤0.01%	2120
2013 Q3	$3.69M	Buy	61,500 +6,905	+13%	+$421K	﹤0.01%	1965
2013 Q2	$3.04M	Buy	+54,595	New	+$3.16M	﹤0.01%	2082

Barclays's COV Position: Q1 2015 in Review

Barclays sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q1 2015, closing a stake of 2,082,091 shares — an estimated $212M sold.

Barclays first reported a position in COV in Q2 2013 and held it in 6 quarters. The position peaked at $253M in Q2 2014. 1 fund tracked by Wall St. Rank holds COV as of Q1 2015.

Barclays reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q1 2015 after selling out during the quarter.
Barclays sold 2,082,091 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q1 2015, an estimated $212M.
Barclays first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2013 and held it in 6 quarters.
Barclays's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $253M in Q2 2014.
1 fund tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q1 2015.

Based on Barclays's 13F filing for Q1 2015, filed 14 May 2015.